DNA polymerases and cancer

Nature Reviews Cancer

Volumn 11, Issue 2, 2011, Pages 96-110

  Lange, Sabine S ^a   Takata, Kei Ichi ^a   Wood, Richard D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA DIRECTED DNA POLYMERASE ALPHA; DNA DIRECTED DNA POLYMERASE BETA; DNA DIRECTED DNA POLYMERASE DELTA; DNA DIRECTED DNA POLYMERASE EPSILON; DNA DIRECTED DNA POLYMERASE ETA; DNA DIRECTED DNA POLYMERASE GAMMA; DNA NUCLEOTIDYLEXOTRANSFERASE; DNA POLYMERASE; POLYMERASE IOTA; POLYMERASE KAPPA; POLYMERASE LAMBDA; POLYMERASE MU; POLYMERASE NU; POLYMERASE THETA; POLYMERASE ZETA; REV1; UNCLASSIFIED DRUG;

CARCINOGENESIS; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; EXCISION REPAIR; GENE EXPRESSION; GENE REPLICATION; GENOME; HUMAN; MAMMAL; MISMATCH REPAIR; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET RADIATION;

CELL TRANSFORMATION, NEOPLASTIC; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 79251481487     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2998     Document Type: Review

References (203)

1. Waters, L. S. et al. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol. Biol. Rev. 73, 134-154 (2009).
2. Bielas, J. H., Loeb, K. R., Rubin, B. P., True, L. D. & Loeb, L. A. Human cancers express a mutator phenotype. Proc. Natl Acad. Sci. USA 103, 18238-18242 (2006).
3. Chang, D. J. & Cimprich, K. A. DNA damage tolerance: when it's OK to make mistakes. Nature Chem. Biol. 5, 82-90 (2009).
4. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008).
5. Hubscher, U., Maga, G. & Spadari, S. Eukaryotic DNA polymerases. Annu. Rev. Biochem. 71, 133-163 (2002).
6. Pursell, Z. F., Isoz, I., Lundstrom, E. B., Johansson, E. & Kunkel, T. A. Yeast DNA polymerase epsilon participates in leading-strand DNA replication. Science 317, 127-130 (2007).
7. McCulloch, S. D. & Kunkel, T. A. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18, 148-161 (2008).
8. Schmitt, M. W., Matsumoto, Y. & Loeb, L. A. High fidelity and lesion bypass capability of human DNA polymerase delta. Biochimie 91, 1163-1172 (2009).
9. McCulloch, S. D. & Kunkel, T. A. The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 18, 148-161(2008).
10. Goldsby, R. E. et al. High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. Proc. Natl Acad. Sci. USA 99, 15560-15565 (2002).
11. Uchimura, A., Hidaka, Y., Hirabayashi, T., Hirabayashi, M. & Yagi, T. DNA polymerase delta is required for early mammalian embryogenesis. PLoS One 4, e4184 (2009).
12. Albertson, T. M. et al. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc. Natl Acad. Sci. USA 106, 17101-17104 (2009).
13. Venkatesan, R. N. et al. Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol. Cell Biol. 27, 7669-7682 (2007).
14. Flohr, T. et al. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines. Int. J. Cancer 80, 919-929 (1999).
15. Daee, D. L., Mertz, T. M. & Shcherbakova, P. V. A cancer-associated DNA polymerase delta variant modeled in yeast causes a catastrophic increase in genomic instability. Proc. Natl Acad. Sci. USA 107, 157-162 (2010).
16. Loeb, L. A. & Monnat, R. J., Jr. DNA polymerases and human disease. Nature Rev. Genet. 9, 594-604 (2008).
17. Hübscher, U., Spadari, S., Villani, G. & Maga, G. DNA Polymerases: Discovery, characterization and functions in cellular DNA transactions (World Scientific, Singapore, 2010).
18. Masutani, C. et al. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J. 18, 3491-3501 (1999).
19. Inui, H. et al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J. Invest. Dermatol. 128, 2055-2068 (2008).
20. Johnson, R. E., Washington, M. T., Prakash, S. & Prakash, L. Fidelity of human DNA polymerase eta. J. Biol. Chem. 275, 7447-7450 (2000).
21. Silverstein, T. D. et al. Structural basis for the suppression of skin cancers by DNA polymerase eta. Nature 465, 1039-1043 (2010).
22. Biertumpfel, C. et al. Structure and mechanism of human DNA polymerase eta. Nature 465, 1044-1048 (2010).
23. Lin, Q. et al. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Cancer Res. 66, 87-94 (2006).
24. Limoli, C. L., Giedzinski, E., Bonner, W. M. & Cleaver, J. E. UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, γ-H2AX formation, and Mre11 relocalization. Proc. Natl Acad. Sci. USA 99, 233-238 (2002).
25. Auclair, Y., Rouget, R., Belisle, J. M., Costantino, S. & Drobetsky, E. A. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase. DNA Repair (Amst) 9, 754-764 (2010).
26. Rey, L. et al. Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication. Mol. Cell Biol. 29, 3344-3354 (2009).
27. Glick, E. et al. Mutations in DNA polymerase eta are not detected in squamous cell carcinoma of the skin. Int. J. Cancer 119, 2225-2227 (2006).
28. Johnson, R. E., Haracska, L., Prakash, S. & Prakash, L. Role of DNA polymerase zeta in the bypass of a (6-4) TT photoproduct. Mol. Cell Biol. 21, 3558-3563 (2001).
29. Yamamoto, J. et al. Translesion synthesis across the (6-4) photoproduct and its Dewar valence isomer by the Y-family and engineered DNA polymerases. Nucleic Acids Symp. Ser. (Oxf.) 52, 339-340 (2008).
30. Szuts, D., Marcus, A. P., Himoto, M., Iwai, S. & Sale, J. E. REV1 restrains DNA polymerase zeta to ensure frame fidelity during translesion synthesis of UV photoproducts in vivo. Nucleic Acids Res. 36, 6767-6780 (2008).
31. Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S. & Prakash, L. Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions. Nature 406, 1015-1019 (2000).
32. Vaisman, A. et al. Sequence context-dependent replication of DNA templates containing UV-induced lesions by human DNA polymerase iota. DNA Repair (Amst) 2, 991-1006 (2003).
33. Dumstorf, C. A. et al. Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer. Proc. Natl Acad. Sci. USA 103, 18083-18088 (2006).
34. Ohkumo, T. et al. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota. Mol. Cell Biol. 26, 7696-7706 (2006).
35. Wang, Y. et al. Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res. 67, 3018-3026 (2007).
36. Jarosz, D. F., Godoy, V. G., Delaney, J. C., Essigmann, J. M. & Walker, G. C. A single amino acid governs enhanced activity of DinB DNA polymerases on damaged templates. Nature 439, 225-228 (2006).
37. Minko, I. G. et al. Replication bypass of the acroleinmediated deoxyguanine DNA-peptide cross-links by DNA polymerases of the DinB family. Chem. Res. Toxicol. 21, 1983-1990 (2008).
38. Minko, I. G. et al. Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand crosslinks. J. Biol. Chem. 283, 17075-17082 (2008).
39. Ogi, T. et al. Expression of human and mouse genes encoding polkappa: testis-specific developmental regulation and AhR-dependent inducible transcription. Genes Cells 6, 943-953 (2001).
40. Ogi, T., Shinkai, Y., Tanaka, K. & Ohmori, H. Pol. kappa protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene. Proc. Natl Acad. Sci. USA 99, 15548-15553 (2002).
41. Stancel, J. N. et al. Polk mutant mice have a spontaneous mutator phenotype. DNA Repair (Amst) 8, 1355-1362 (2009).
42. Masutani, C., Kusumoto, R., Iwai, S. & Hanaoka, F. Mechanisms of accurate translesion synthesis by human DNA polymerase eta. EMBO J. 19, 3100-3109 (2000).
43. Colis, L. C., Raychaudhury, P. & Basu, A. K. Mutational specificity of gamma-radiation-induced guaninethymine and thymine-guanine intrastrand cross-links in mammalian cells and translesion synthesis past the guanine-thymine lesion by human DNA polymerase eta. Biochemistry 47, 8070-8079 (2008).
44. Lee, D. H. & Pfeifer, G. P. Translesion synthesis of 7, 8-dihydro-8-oxo-2'-deoxyguanosine by DNA polymerase eta in vivo. Mutat. Res. 641, 19-26 (2008).
45. Minko, I. G. et al. Translesion synthesis past acrolein-derived DNA adduct, gamma -hydroxypropanodeoxyguanosine, by yeast and human DNA polymerase eta. J. Biol. Chem. 278, 784-790 (2003).
46. Shachar, S. et al. Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals. EMBO J. 28, 383-393 (2009).
47. Albertella, M. R., Green, C. M., Lehmann, A. R. & O'Connor, M. J. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res. 65, 9799-9806 (2005).
48. Betous, R. et al. Role of TLS DNA polymerases eta and kappa in processing naturally occurring structured DNA in human cells. Mol. Carcinog. 48, 369-378 (2009).
49. Obeid, S. et al. Replication through an abasic DNA lesion: structural basis for adenine selectivity. EMBO J. 29, 1738-1747 (2010).
50. Avkin, S., Adar, S., Blander, G. & Livneh, Z. Quantitative measurement of translesion replication in human cells: evidence for bypass of abasic sites by a replicative DNA polymerase. Proc. Natl Acad. Sci. USA 99, 3764-3769 (2002).
51. Seki, M. et al. High-efficiency bypass of DNA damage by human DNA polymerase, Q. EMBO J. 23, 4484-4494 (2004).
52. Arana, M. E., Seki, M., Wood, R. D., Rogozin, I. B. & Kunkel, T. A. Low-fidelity DNA synthesis by human DNA polymerase theta. Nucleic Acids Res. 36, 3847-3856 (2008).
53. Kusumoto, R., Masutani, C., Iwai, S. & Hanaoka, F. Translesion synthesis by human DNA polymerase eta across thymine glycol lesions. Biochemistry 41, 6090-6099 (2002).
54. Yoon, J. H., Bhatia, G., Prakash, S. & Prakash, L. Error-free replicative bypass of thymine glycol by the combined action of DNA polymerases kappa and zeta in human cells. Proc. Natl Acad. Sci. USA 107, 14116-14121 (2010).
55. Marini, F., Kim, N., Schuffert, A. & Wood, R. D. POLN, a nuclear PolA family DNA polymerase homologous to the DNA cross-link sensitivity protein Mus308. J. Biol. Chem. 278, 32014-32019 (2003).
56. Takata, K. I., Shimizu, T., Iwai, S. & Wood, R. D. Human DNA polymerase N. (POLN) is a low-fidelity enzyme capable of error-free bypass of 5S-thymine glycol. J. Biol. Chem. 281, 23445-23455 (2006).
57. Takata, K. I., Arana, M. E., Seki, M., Kunkel, T. A. & Wood, R. D. Evolutionary conservation of residues in vertebrate DNA polymerase N conferring low fidelity and bypass activity. Nucleic Acids Res. 38, 3233-3244 (2010).
58. Yamanaka, K. et al. Novel Enzymatic Function of DNA Polymerase nu in Translesion DNA Synthesis Past Major Groove DNA-Peptide and DNA-DNA Cross-Links. Chem. Res. Toxicol. 23, 689-695 (2010).
59. Arana, M. E., Takata, K., Garcia-Diaz, M., Wood, R. D. & Kunkel, T. A. A unique error signature for human DNA polymerase ν. DNA Repair (Amst) 6, 213-223 (2007).
60. Zietlow, L., Smith, L. A., Bessho, M. & Bessho, T. Evidence for the involvement of human DNA polymerase N. in the repair of DNA interstrand crosslinks. Biochemistry 48, 11817-11824 (2009).
61. Moldovan, G. L. et al. DNA polymerase POLN participates in cross-link repair and homologous recombination. Mol. Cell Biol. 30, 1088-1096 (2010).
62. Yoshimura, M. et al. Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Mol. Cell 24, 115-125 (2006).
63. Kohzaki, M. et al. DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken. J. Cell Biol. 189, 1117-1127 (2010).
64. Shivapurkar, N. et al. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res. 59, 3576-3580 (1999).
65. Holbeck, S. L. & Strathern, J. N. A role for REV3 in mutagenesis during double-strand break repair in Saccharomyces cerevisiae. Genetics 147, 1017-1024 (1997).
66. Abdulovic, A. L. & Jinks-Robertson, S. The in vivo characterization of translesion synthesis across UV-induced lesions in Saccharomyces cerevisiae: insights into Pol. zeta-and Pol. eta-dependent frameshift mutagenesis. Genetics 172, 1487-1498 (2006).
67. Hirano, Y. & Sugimoto, K. ATR homolog Mec1 controls association of DNA polymerase zeta-Rev1 complex with regions near a double-strand break. Curr. Biol. 16, 586-590 (2006).
68. Gibbs, P. E., McGregor, W. G., Maher, V. M., Nisson, P. & Lawrence, C. W. A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc. Natl Acad. Sci. USA 95, 6876-6880 (1998).
69. Murakumo, Y. et al. Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J. Biol. Chem. 276, 35644-35651 (2001).
70. Jansen, J. G. et al. Mammalian polymerase zeta is essential for post-replication repair of UV-induced DNA lesions. DNA Repair (Amst) 8, 1444-1451 (2009).
71. Takata, K. & Wood, R. D. Bypass specialists work together. EMBO J. 28, 313-314 (2009).
72. Bemark, M., Khamlichi, A. A., Davies, S. L. & Neuberger, M. S. Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr. Biol. 10, 1213-1216 (2000).
73. Esposito, G. et al. Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality. Curr. Biol. 10, 1221-1224 (2000).
74. Wittschieben, J. et al. Disruption of the developmentally regulated Rev3l gene causes embryonic lethality. Curr. Biol. 10, 1217-1220 (2000).
75. Van Sloun, P. P. et al. Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage. Mol. Cell Biol. 22, 2159-2169 (2002).
76. O-Wang, J. et al. An essential role for REV3 in mammalian cell survival: absence of REV3 induces p53-independent embryonic death. Biochem. Biophys. Res. Commun. 293, 1132-1137 (2002).
77. Li, Z. et al. hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts. Mutat. Res. 510, 71-80 (2002).
78. Diaz, M. et al. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta. Mol. Cancer Res. 1, 836-847 (2003).
79. Sonoda, E. et al. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22, 3188-3197 (2003).
80. Wu, F., Lin, X., Okuda, T. & Howell, S. B. DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance. Cancer Res. 64, 8029-8035 (2004).
81. Okada, T. et al. Multiple roles of vertebrate REV genes in DNA repair and recombination. Mol. Cell Biol. 25, 6103-6111 (2005).
82. Wittschieben, J. P., Reshmi, S. C., Gollin, S. M. & Wood, R. D. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res. 66, 134-142 (2006).
83. Gueranger, Q. et al. Role of DNA polymerases eta, iota and zeta in UV resistance and UV-induced mutagenesis in a human cell line. DNA Repair (Amst) 7, 1551-1562 (2008).
84. Roos, W. P. et al. The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs. Mol. Pharmacol. 76, 927-934 (2009).
85. Wittschieben, J. P. et al. Loss of DNA polymerase zeta enhances spontaneous tumorigenesis. Cancer Res. 70, 2770-2778 (2010).
86. Schenten, D. et al. Pol. zeta ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability. J. Exp. Med. 206, 477-490 (2009).
87. Morelli, C. et al. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 21, 7266-7276 (2002).
88. Nelson, J. R., Lawrence, C. W. & Hinkle, D. C. Thymine-thymine dimer bypass by yeast DNA polymerase zeta. Science 272, 1646-1649 (1996).
89. Lemontt, J. F. Mutants of Yeast Defective in Mutation Induced by Ultraviolet Light. Genetics 68, 21-33 (1971).
90. Simpson, L. J. & Sale, J. E. Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 22, 1654-1664 (2003).
91. Jansen, J. G. et al. The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis. Nucleic Acids Res. 33, 356-365 (2005).
92. Jansen, J. G. et al. Separate domains of Rev1 mediate two modes of DNA damage bypass in mammalian cells. Mol. Cell Biol. 29, 3113-3123 (2009).
93. Jansen, J. G. et al. Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice. J. Exp. Med. 203, 319-323 (2006).
94. Masuda, K. et al. A critical role for REV1 in regulating the induction of C:G. transitions and A:T mutations during Ig gene hypermutation. J. Immunol. 183, 1846-1850 (2009).
95. Tsaalbi-Shtylik, A. et al. Error-prone translesion replication of damaged DNA suppresses skin carcinogenesis by controlling inflammatory hyperplasia. Proc. Natl Acad. Sci. USA 106, 21836-21841 (2009).
96. Lin, W. et al. The human REV1 gene codes for a DNA template-dependent dCMP transferase. Nucleic Acids Res. 27, 4468-4475 (1999).
97. Hlavin, E. M., Smeaton, M. B., Noronha, A. M., Wilds, C. J. & Miller, P. S. Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells. Biochemistry 49, 3977-3988 (2010).
98. Ross, A. L., Simpson, L. J. & Sale, J. E. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res. 33, 1280-1289 (2005).
99. Lehmann, A. R. et al. Translesion synthesis: Y-family polymerases and the polymerase switch. DNA Repair (Amst) 6, 891-899 (2007).
100. Andersen, P. L., Xu, F. & Xiao, W. Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res. 18, 162-173 (2007).
101. Terai, K., Abbas, T., Jazaeri, A. A. & Dutta, A. CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Mol. Cell 37, 143-149 (2010).
102. Bienko, M. et al. Regulation of translesion synthesis DNA polymerase eta by monoubiquitination. Mol. Cell 37, 396-407 (2010).
103. Pastushok, L., Hanna, M. & Xiao, W. Constitutive fusion of ubiquitin to PCNA provides DNA damage tolerance independent of translesion polymerase activities. Nucleic Acids Res. 28, 5047-5058 (2010).
104. Guo, C. et al. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J. 22, 6621-6630 (2003).
105. Ohashi, E. et al. Interaction of hREV1 with three human Y-family DNA polymerases. Genes Cells 9, 523-531 (2004).
106. Yuasa, M. S. et al. A human DNA polymerase eta complex containing Rad18, Rad6 and Rev1; proteomic analysis and targeting of the complex to the chromatin-bound fraction of cells undergoing replication fork arrest. Genes Cells 11, 731-744 (2006).
107. Ohashi, E. et al. Identification of a novel REV1-interacting motif necessary for DNA polymerase kappa function. Genes Cells 14, 101-111 (2009).
108. Guo, C. et al. REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. Mol. Cell 23, 265-271 (2006).
109. Edmunds, C. E., Simpson, L. J. & Sale, J. E. PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40. Mol. Cell 30, 519-529 (2008).
110. McCulloch, S. D., Kokoska, R. J. & Kunkel, T. A. Efficiency, fidelity and enzymatic switching during translesion DNA synthesis. Cell Cycle 3, 580-583 (2004).
111. Ogawara, D. et al. Near-full-length REV3L appears to be a scarce maternal factor in Xenopus laevis eggs that changes qualitatively in early embryonic development. DNA Repair (Amst) 9, 90-95 (2010).
112. Lopes, M., Foiani, M. & Sogo, J. M. Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. Mol. Cell 21, 15-27 (2006).
113. Daigaku, Y., Davies, A. A. & Ulrich, H. D. Ubiquitindependent DNA damage bypass is separable from genome replication. Nature 465, 951-955 (2010).
114. Daigaku, Y., Davies, A. A. & Ulrich, H. D. Ubiquitin-dependent DNA damage bypass is separable from genome replication. Nature 465, 951-955 (2010).
115. Waters, L. S. & Walker, G. C. The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G2/M phase rather than S phase. Proc. Natl Acad. Sci. USA 103, 8971-8976 (2006).
116. Putnam, C. D., Hayes, T. K. & Kolodner, R. D. Postreplication repair suppresses duplication-mediated genome instability. PLoS Genet. 6, e1000933 (2010).
117. Karras, G. I. & Jentsch, S. The RAD6 DNA damage tolerance pathway operates uncoupled from the replication fork and is functional beyond S. phase. Cell 141, 255-267 (2010).
118. Almeida, K. H. & Sobol, R. W. A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) 6, 695-711 (2007).
119. Copeland, W. C. The mitochondrial DNA polymerase in health and disease. Subcell. Biochem. 50, 211-222 (2010).
120. Starcevic, D., Dalal, S. & Sweasy, J. B. Is there a link between DNA polymerase beta and cancer- Cell Cycle 3, 998-1001 (2004).
121. Sweasy, J. B. et al. Expression of DNA polymerase β cancer-associated variants in mouse cells results in cellular transformation. Proc. Natl Acad. Sci. USA 102, 14350-14355 (2005).
122. Cabelof, D. C. et al. Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate. Cancer Res. 66, 7460-7465 (2006).
123. Bebenek, K. et al. 5′-Deoxyribose phosphate lyase activity of human DNA polymerase iota in vitro. Science 291, 2156-2159 (2001).
124. Braithwaite, E. K. et al. DNA polymerase lambda mediates a back-up base excision repair activity in extracts of mouse embryonic fibroblasts. J. Biol. Chem. 280, 18469-18475 (2005).
125. Prasad, R. et al. Human DNA polymerase θ possesses 5'-dRP lyase activity and functions in single-nucleotide base excision repair in vitro. Nucleic Acids Res. 37, 1868-1877 (2009).
126. Petta, T. B. et al. Human DNA polymerase iota protects cells against oxidative stress. EMBO J. 27, 2883-2895 (2008).
127. Prasad, R. et al. Localization of the deoxyribose phosphate lyase active site in human DNA polymerase iota by controlled proteolysis. J. Biol. Chem. 278, 29649-29654 (2003).
128. van Loon, B., Markkanen, E. & Hubscher, U. Oxygen as a friend and enemy: How to combat the mutational potential of 8-oxo-guanine. DNA Repair (Amst) 9, 604-616 (2010).
129. Goff, J. P. et al. Lack of DNA polymerase theta (POLQ) radiosensitizes bone marrow stromal cells in vitro and increases reticulocyte micronuclei after total-body irradiation. Radiation Research 172, 165-174 (2009).
130. Shivji, M. K., Podust, V. N., Hubscher, U. & Wood, R. D. Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry 34, 5011-5017 (1995).
131. Ogi, T. et al. Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Mol. Cell 37, 714-727 (2010).
132. Friedberg, E. C. et al. DNA repair and mutagenesis, 2nd edition (ASM Press, Washington, DC, 2006).
133. Kidane, D. et al. DNA polymerase beta is critical for mouse meiotic synapsis. EMBO J. 29, 410-423 (2010).
134. Kawamoto, T. et al. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol. Cell 20, 793-799 (2005).
135. McIlwraith, M. J. & West, S. C. DNA repair synthesis facilitates RAD52-mediated second-end capture during DSB repair. Mol. Cell 29, 510-516 (2008).
136. Rattray, A. J., Shafer, B. K., McGill, C. B. & Strathern, J. N. The roles of REV3 and RAD57 in double-strand-break-repair-induced mutagenesis of Saccharomyces cerevisiae. Genetics 162, 1063-1077 (2002).
137. Shen, X. et al. REV3 and REV1 play major roles in recombination- independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J. Biol. Chem. 281, 13869-13872 (2006).
138. Zhang, N., Liu, X., Li, L. & Legerski, R. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA Repair (Amst) 6, 1670-1678 (2007).
139. Mahajan, K. N. et al. Association of terminal deoxynucleotidyl transferase with Ku. Proc. Natl Acad. Sci. USA 96, 13926-13931 (1999).
140. Ma, Y. et al. A biochemically defined system for mammalian nonhomologous DNA end joining. Mol. Cell 16, 701-713 (2004).
141. Bebenek, K., Garcia-Diaz, M., Zhou, R. Z., Povirk, L. F. & Kunkel, T. A. Loop 1 modulates the fidelity of DNA polymerase a;. Nucleic Acids Res. 38, 5419-5431 (2010).
142. Andrade, P., Martin, M. J., Juarez, R., Lopez de Saro, F. & Blanco, L. Limited terminal transferase in human DNA polymerase mu defines the required balance between accuracy and efficiency in NHEJ. Proc. Natl Acad. Sci. USA 106, 16203-16208 (2009).
143. Desiderio, S. V. et al. Insertion of N. regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311, 752-755 (1984).
144. Bertocci, B., De Smet, A., Weill, J. C. & Reynaud, C. A. Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity 25, 31-41 (2006).
145. Lucas, D. et al. Altered hematopoiesis in mice lacking DNA polymerase mu is due to inefficient doublestrand break repair. PLoS Genet. 5, e1000389 (2009).
146. Chayot, R., Danckaert, A., Montagne, B. & Ricchetti, M. Lack of DNA polymerase mu affects the kinetics of DNA double-strand break repair and impacts on cellular senescence. DNA Repair (Amst) 9, 1187-1199 (2010).
147. Bertocci, B., De Smet, A., Berek, C., Weill, J. C. & Reynaud, C. A. Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu. Immunity 19, 203-211 (2003).
148. Higgins, G. S. et al. A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown. Cancer Res. 70, 2984-2993 (2010).
149. Shima, N., Munroe, R. J. & Schimenti, J. C. The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm. Mol. Cell Biol. 24, 10381-10389 (2004).
150. Yu, A. M. & McVey, M. Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions. Nucleic Acids Res. (2010).
151. Chan, S. H., Yu, A. M. & McVey, M. Dual Roles for DNA polymerase theta in alternative end-joining repair of double-strand breaks in Drosophila. PLoS Genet. 6, e1001005 (2010).
152. Brondello, J. M. et al. Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene 27, 6093-6101 (2008).
153. Pan, Q., Fang, Y., Xu, Y., Zhang, K. & Hu, X. Downregulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers. Cancer Lett. 217, 139-147 (2005).
154. Lemée, F. et al. POLQ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication and promotes genetic instability Proc. Natl Acad. Sci. (USA) 107, 13390-13395 (2010).
155. Albertella, M. R., Lau, A. & O'Connor, M. J. The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst) 4, 583-593 (2005).
156. O-Wang, J. et al. DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res. 61, 5366-5369 (2001).
157. Wang, H. et al. Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance. Neuro Oncol. 12, 679-686 (2010).
158. Liu, P. Y. et al. Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus. Cancer Res. 69, 6290-6298 (2009).
159. Ceppi, P. et al. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin. Cancer Res. 15, 1039-1045 (2009).
160. Tan, X. H. et al. Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach. Cancer Lett. 220, 101-114 (2005).
161. Yoshizawa, K. et al. Gastrointestinal hyperplasia with altered expression of DNA polymerase beta. PLoS One 4, e6493 (2009).
162. Pillaire, M. J. et al. Upregulation of error-prone DNA polymerases beta and kappa slows down fork progression without activating the replication checkpoint. Cell Cycle 6, 471-477 (2007).
163. Chan, K. et al. Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair. Mutagenesis 22, 183-188 (2007).
164. Kawamura, K. et al. DNA polymerase θ is preferentially expressed in lymphoid tissues and upregulated in human cancers. Int. J. Cancer 109, 9-16 (2004).
165. Pillaire, M. J. et al. A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene 29, 876-887 (2010).
166. Higgins, G. S. et al. Overexpression of POLQ confers a poor prognosis in early breast cancer patients. Oncotarget 1, 175-184 (2010).
167. Kuriyama, I. et al. Effect of dehydroaltenusin-C12 derivative, a selective DNA polymerase alpha inhibitor, on DNA replication in cultured cells. Molecules 13, 2948-2961 (2008).
168. Kuramochi, K. et al. Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase alpha inhibitors. Bioorg Med. Chem. 17, 7227-7238 (2009).
169. Maeda, N. et al. Anti-tumor effects of dehydroaltenusin, a specific inhibitor of mammalian DNA polymerase alpha. Biochem. Biophys. Res. Commun. 352, 390-396 (2007).
170. Kumamoto-Yonezawa, Y. et al. Enhancement of human cancer cell radiosensitivity by conjugated eicosapentaenoic acid - a mammalian DNA polymerase inhibitor. Int. J. Oncol. 36, 577-584 (2010).
171. Mizushina, Y. et al. The inhibitory action of kohamaic acid A derivatives on mammalian DNA polymerase beta. Molecules 14, 102-121 (2009).
172. Gao, Z., Maloney, D. J., Dedkova, L. M. & Hecht, S. M. Inhibitors of DNA polymerase beta: activity and mechanism. Bioorg Med. Chem. 16, 4331-4340 (2008).
173. Stachelek, G. C. et al. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res. 70, 409-417 (2010).
174. Jaiswal, A. S. et al. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells. Mol. Cancer Res. 7, 1973-1983 (2009).
175. Yang, J. et al. Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy. Oncogene 29, 463-468 (2010).
176. Mizushina, Y. et al. 3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain. Mar. Drugs 7, 624-639 (2009).
177. Dorjsuren, D. et al. A real-time fluorescence method for enzymatic characterization of specialized human DNA polymerases. Nucleic Acids Res. 37, e128 (2009).
178. Dumstorf, C. A., Mukhopadhyay, S., Krishnan, E., Haribabu, B. & McGregor, W. G. REV1 is implicated in the development of carcinogen-induced lung cancer. Mol. Cancer Res. 7, 247-254 (2009).
179. Xie, K., Doles, J., Hemann, M. T. & Walker, G. C. Errorprone translesion synthesis mediates acquired chemoresistance. Proc. Natl Acad. Sci. USA 107, 20792-20797 (2010).
180. Doles, J. et al. Suppression of Rev3, the catalytic subunit of Pol ζ, sensitizes drug-resistant lung tumors to chemotherapy. Proc. Natl Acad. Sci. USA 107, 20786-20791 (2010).
181. Swan, M. K., Johnson, R. E., Prakash, L., Prakash, S. & Aggarwal, A. K. Structure of the human Rev1-DNA-dNTP ternary complex. J. Mol. Biol. 390, 699-709 (2009).
182. Nair, D. T., Johnson, R. E., Prakash, S., Prakash, L. & Aggarwal, A. K. Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing. Nature 430, 377-380 (2004).
183. Lemée, F. et al. POLQ up-regulation is associated with poor survival in breast cancer, perturbs DNA replication and promotes genetic instability Proc. Natl Acad. Sci. USA 107, 13390-13395 (2010).
184. Hegi, M. E. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352, 997-1003 (2005).
185. Bhagwat, N. R. et al. Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res. 69, 6831-6838 (2009).
186. King, N. M. et al. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts. DNA Repair (Amst) 4, 714-724 (2005).
187. Ohmori, H., Hanafusa, T., Ohashi, E., Vaziri, C. Separate Roles of Structured and Unstructured Regions of Y-Family DNA Polymerases. Adv. in Prot. Chem. and Struc. Biol. 78, 99-146 (2009).
188. Boudsocq, F. et al. Investigating the role of the little finger domain of Y-family DNA polymerases in low fidelity synthesis and translesion replication. J. Biol. Chem. 279, 32932-32940 (2004).
189. Betz, K. et al. Structures of DNA polymerases caught processing size-augmented nucleotide probes. Angew. Chem. Int. Ed Engl. 49, 5181-5184 (2010).
190. Zeng, X. et al. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nature Immunol. 2, 537-541 (2001).
191. Delbos, F., Aoufouchi, S., Faili, A., Weill, J. C. & Reynaud, C. A. DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 204, 17-23 (2007).
192. Martomo, S. A., Saribasak, H., Yokoi, M., Hanaoka, F. & Gearhart, P. J. Reevaluation of the role of DNA polymerase theta in somatic hypermutation of immunoglobulin genes. DNA Repair (Amst) 7, 1603-1608 (2008).
193. Ross, A. L. & Sale, J. E. The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. Mol. Immunol. 43, 1587-1594 (2006).
194. Hance, N., Ekstrand, M. I. & Trifunovic, A. Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis. Hum. Mol. Genet. 14, 1775-1783 (2005).
195. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H. & Rajewsky, K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106 (1994).
196. Sugo, N., Aratani, Y., Nagashima, Y., Kubota, Y. & Koyama, H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. EMBO J. 19, 1397-1404 (2000).
197. Sugo, N., Niimi, N., Aratani, Y., Takiguchi-Hayashi, K. & Koyama, H. p53 Deficiency rescues neuronal apoptosis but not differentiation in DNA polymerase betadeficient mice. Mol. Cell Biol. 24, 9470-9477 (2004).
198. Delbos, F. et al. Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 201, 1191-1196 (2005).
199. McDonald, J. P. et al. 129-derived strains of mice are deficient in DNA polymerase iota and have normal immunoglobulin hypermutation. J. Exp. Med. 198, 635-643 (2003).
200. Schenten, D. et al. DNA polymerase kappa deficiency does not affect somatic hypermutation in mice. Eur. J. Immunol. 32, 3152-3160 (2002).
201. Shima, N. et al. Phenotype-based identification of mouse chromosome instability mutants. Genetics 163, 1031-1040 (2003).
202. Friedberg, E. C. & Meira, L. B. Database of mouse strains carrying targeted mutations in genes affecting biological responses to DNA damage Version 7. DNA Repair (Amst) 5, 189-209 (2006).
203. Berdis, A. DNA polymerases as therapeutic targets. Biochemistry 47, 8253-8260 (2008).